Milestone Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Montreal, Quebec, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Milestone Pharmaceuticals Inc. has filed 416 SEC EDGAR filings since 30 Jul 2007

SEC filing history

Showing 101-125 of 415 matching filings.

Per page
25
Current page
5
EFFECT File 333-283162

EFFECT filing

Filing date
22 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
20 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-283162

UPLOAD filing

Filing date
19 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-283162

S-3

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-283160

FORM S-8

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91001

SC 13G/A filing

Filing date
29 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Sep 2024
Reporting date
03 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Sep 2024
Reporting date
03 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Aug 2024
Reporting date
28 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Aug 2024
Reporting date
28 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Aug 2024
Reporting date
28 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Aug 2024
Reporting date
28 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Aug 2024
Reporting date
28 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Aug 2024
Reporting date
28 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2024
Reporting date
15 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Jul 2024
Reporting date
15 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2024
Reporting date
15 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Jul 2024
Reporting date
15 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91001

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Filing date
16 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38899

ARS

Filing date
15 Jul 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .